- Home
- VRME vs NXTC Comparison
VRME vs NXTC Comparison
Compare VRME & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- NXTC
- Stock Information
- Founded
- VRME 1999
- NXTC 2015
- Country
- VRME United States
- NXTC United States
- Employees
- VRME N/A
- NXTC N/A
- Industry
- VRME EDP Services
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- VRME Technology
- NXTC Health Care
- Exchange
- VRME Nasdaq
- NXTC Nasdaq
- Market Cap
- VRME 11.0M
- NXTC 13.0M
- IPO Year
- VRME N/A
- NXTC 2019
- Fundamental
- Price
- VRME $0.82
- NXTC $5.40
- Analyst Decision
- VRME Strong Buy
- NXTC Strong Buy
- Analyst Count
- VRME 2
- NXTC 2
- Target Price
- VRME $1.50
- NXTC $25.50
- AVG Volume (30 Days)
- VRME 150.1K
- NXTC 16.9K
- Earning Date
- VRME 11-11-2025
- NXTC 11-06-2025
- Dividend Yield
- VRME N/A
- NXTC N/A
- EPS Growth
- VRME N/A
- NXTC N/A
- EPS
- VRME N/A
- NXTC N/A
- Revenue
- VRME $22,071,000.00
- NXTC N/A
- Revenue This Year
- VRME N/A
- NXTC N/A
- Revenue Next Year
- VRME $5.98
- NXTC N/A
- P/E Ratio
- VRME N/A
- NXTC N/A
- Revenue Growth
- VRME N/A
- NXTC N/A
- 52 Week Low
- VRME $0.55
- NXTC $2.69
- 52 Week High
- VRME $5.00
- NXTC $19.20
- Technical
- Relative Strength Index (RSI)
- VRME 43.78
- NXTC 57.83
- Support Level
- VRME $0.80
- NXTC $4.77
- Resistance Level
- VRME $0.94
- NXTC $5.15
- Average True Range (ATR)
- VRME 0.05
- NXTC 0.22
- MACD
- VRME -0.01
- NXTC 0.05
- Stochastic Oscillator
- VRME 11.11
- NXTC 86.90
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.